Investments
7Latest Magna Capital Partners News
Mar 4, 2021
Israel: TechsoMed, developer of first of its kind AI and Algorithm powered real-time tissue damage imaging technology (BioTrace), announced today it has closed a US$7 Million Series B equity financing round, led by Axil Capital with the participation of Yongjin Capital, Cobro Ventures, Magna Capital Partners and Radianx Capital, along with the company’s existing investors – Johnson & Johnson Innovation – JJDC, Inc., and NextLeap Ventures. Following clinical and regulatory approval, the company’s technology has the potential to help physicians ensure treatment accuracy and increase treatment efficacy. TechsoMed is collaborating with leading medical centers world-wide, in efforts to secure regulatory approval for its BioTrace system in liver tumor ablation through the De Novo process established by the FDA. In parallel, the BioTrace system is also being developed to support cardiac and pain ablation procedures. “We are very grateful to both our new and existing investors for sharing our vision and recognizing the valuable impact that our technology brings. Coming from diverse regional markets such as the U.S., Japan, China and the EU, our investors act as driving force towards achieving our goals for scaling our technology and company,” said Yossi Abu, CEO, TechsoMed.” With our BioTrace solution and advanced algorithm and image processing technologies, physicians will be able to see more in real time. We hope to eliminate the guess work in ablation therapy.”
Magna Capital Partners Investments
7 Investments
Magna Capital Partners has made 7 investments. Their latest investment was in Aviva as part of their Pre-Seed on December 20, 2022.
Magna Capital Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
12/20/2022 | Pre-Seed | Aviva | $2.2M | Yes | 500 Global, Newtopia VC, Seedstars, Undisclosed Angel Investors, Wollef, and Xtraordinary Venture Partners | 4 |
4/22/2021 | Series A | |||||
3/3/2021 | Series B | |||||
11/23/2020 | Seed VC - II | |||||
6/23/2014 | Series B |
Date | 12/20/2022 | 4/22/2021 | 3/3/2021 | 11/23/2020 | 6/23/2014 |
---|---|---|---|---|---|
Round | Pre-Seed | Series A | Series B | Seed VC - II | Series B |
Company | Aviva | ||||
Amount | $2.2M | ||||
New? | Yes | ||||
Co-Investors | 500 Global, Newtopia VC, Seedstars, Undisclosed Angel Investors, Wollef, and Xtraordinary Venture Partners | ||||
Sources | 4 |
Magna Capital Partners Team
2 Team Members
Magna Capital Partners has 2 team members, including current Investment Partner, Shimon Elkabetz.
Name | Work History | Title | Status |
---|---|---|---|
Shimon Elkabetz | Investment Partner | Current | |
Name | Shimon Elkabetz | |
---|---|---|
Work History | ||
Title | Investment Partner | |
Status | Current |
Loading...